# Redefining the Axillary Aesthetic: Surgical Management of Axillary Tissue Hypertrophy

**Authors:** Neil Tanna, Sarah Barnett, Christopher Aiello, Lucas M. Boehm, M. Bradley Calobrace

PMC · DOI: 10.3390/medicina60010126 · Medicina · 2024-01-10

## TL;DR

This paper presents a surgical technique for treating axillary tissue hypertrophy, focusing on aesthetic improvement and patient comfort.

## Contribution

The study introduces a specific surgical technique combining dermato-lipectomy and glandular excision for axillary contouring.

## Key findings

- All 35 patients experienced aesthetic deformity and discomfort due to axillary tissue hypertrophy.
- Histological analysis confirmed benign breast and adipose tissue in all specimens.
- Complications included hypertrophic scarring, seroma, and axillary cording.

## Abstract

Background and Objectives: Axillary tissue hypertrophy consists of ectopic breast tissue and occurs in up to six percent of women. Women complain of pain, interference with activity, and dissatisfaction with appearance. While it is recommended that accessory breast tissue be removed via surgical excision, there is lack of consensus on the best technique for the surgical management of axillary tissue hypertrophy. In this study, the senior authors (BC and NT) review outcomes and complications as they pertain to the surgical treatment of axillary tissue hypertrophy and axillary contouring. Materials and Methods: A retrospective review of all patients (n = 35), from two separate institutions, who presented with axillary tissue hypertrophy between December 2019 and August 2021 was conducted. All patients underwent a technique that included direct crescentic dermato-lipectomy and glandular excision with axillary crease obliteration. Tissue was sent for histological analysis after removal. During a six-month follow-up period, all patient outcomes were recorded. Results: The authors treated 35 women with axillary tissue hypertrophy. All patients complained of aesthetic deformity with significant discomfort leading to the desire for surgery. Histologically, all specimens contained benign breast and adipose tissue. Hypertrophic scarring, seroma, and axillary cording were noted complications. Conclusions: Detailed is the surgical management and optimal technique that can be used to treat both adipose and fibroglandular axillary tissue hypertrophy while simultaneously providing a favorable axillary aesthetic.

## Full-text entities

- **Genes:** PGR (progesterone receptor) [NCBI Gene 5241] {aka NR3C3, PR}, ESR1 (estrogen receptor 1) [NCBI Gene 2099] {aka ER, ESR, ESRA, ESTRR, Era, NR3A1}
- **Diseases:** functional impairment (MESH:D003072), malignancy (MESH:D009369), hematoma (MESH:D006406), Complications (MESH:D008107), macromastia (MESH:C536821), anxiety (MESH:D001007), necrosis (MESH:D009336), Seroma (MESH:D049291), postoperative (MESH:D019106), Hypertrophic (MESH:D002312), ALND (MESH:D000072717), Axillary ectopic breast (MESH:D061325), deformity (MESH:D009140), skin irritation (MESH:D012871), axillary tissue excess (MESH:D006970), breast cancer (MESH:D001943), hyperpigmentation (MESH:D017495), obese (MESH:D009765), restriction of arm movement (MESH:D002313), postoperative complications (MESH:D011183), AWS (MESH:C563636), Hypertrophic Scarring (MESH:D017439), tissue (MESH:D017695), 19 (MESH:D000094024), injury to people or property (MESH:C000719191), scars (MESH:D002921), Axillary Tissue Hypertrophy (MESH:D006984), tenderness (MESH:D063806), infection (MESH:D007239), pain (MESH:D010146), Axillary cording (MESH:D013118), wound dehiscence (MESH:D013529)
- **Chemicals:** formalin (MESH:D005557), 2-octyl cyanoacrylate (MESH:C100832)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC10821127/full.md

## Figures

8 figures with captions in the complete paper: https://tomesphere.com/paper/PMC10821127/full.md

## References

24 references — full list in the complete paper: https://tomesphere.com/paper/PMC10821127/full.md

---
Source: https://tomesphere.com/paper/PMC10821127